Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosurveillance

    Study Shows Potential for Wastewater-Based Epidemiology to Monitor Monkeypox

    By Global Biodefense StaffSeptember 9, 2022
    3 large open flasks atop a drip arrangement of filters in a laboratory
    This photograph was captured during one of the steps in an environmental surveillance technique, using a filtration-based method. The benefits include not having to be incubated overnight in the cold, and that it uses three filters at one time, proving to be faster, and cheaper. Credit: CDC / Holly Patrick, MS, MPH
    Share
    Facebook LinkedIn Reddit Email

    Gaps in current clinical testing availability for monkeypox and the lag from infection to symptoms suggest the potential utility of wastewater-based epidemiology to monitor community level spread and prevalence.

    In a new study, researchers demonstrate how wastewater epidemiology — widely applied to monitor SARS-CoV-2 transmission — could be optimized for monkeypox, potentially detecting as few as seven infections per 100,000 people.

    Like SARS-CoV-2, the monkeypox virus can shed from infected people through their feces, urine and saliva. Recently, researchers have detected its DNA in wastewater using polymerase chain reaction (PCR) assays. However, monitoring current monkeypox outbreaks in the U.S. with wastewater-based epidemiology has been limited, despite its success in tracking community-level SARS-CoV-2 prevalence. So, Kyle Bibby and William Chen wanted to evaluate the feasibility of this technique for detecting monkeypox viral DNA in different wastewater scenarios.

    The researchers collected information from previous scientific studies about the shedding of monkeypox viral DNA from saliva, stool and urine into wastewater streams. They analyzed that data in combination with people’s daily water usage, concluding that infected people can shed from 13,000 to 208 billion genome copies daily into sewers, with most of that amount coming from stool. These results indicated that a single PCR assay conducted at the lowest level of sensitivity, or 10 genome copies per liter of wastewater, could theoretically detect seven cases out of 100,000 people at the average U.S. wastewater treatment plant. In addition, replicate assays could likely identify even lower infection rates.

    Next, the team developed a computer-based strategy to determine the number of PCR assays that would need to be run for wastewater samples collected in the U.S. and other countries, depending on the expected case rates of monkeypox and the desired level of sensitivity. For the U.S., at the average case rate as of July 15, 2022, each sample would need eight replicate assays using a moderately high level of sensitivity to correctly detect monkeypox in the sewage, whereas at a suspected maximum case rate (0.0012%) only four replicates at a lower level of sensitivity would be needed. Since mid-July, case rates have likely increased, so the researchers predict that a lower number of replicates could be implemented now in the U.S.

    There is still a lack of information about monkeypox DNA shedding from humans and its persistence in wastewater, which merits further study. This computer model can nonetheless be a useful framework for developing robust community monitoring programs.

    Model-Based Theoretical Evaluation of the Feasibility of Using Wastewater-Based Epidemiology to Monitor Monkeypox. Environmental Science & Technology Letters, 1 September 2022.

    Editor Pick Emerging Threats Epidemiology mpox Public Health Emergency Wastewater Surveillance
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleThere is No Cure for Polio. The Only Treatment is Prevention.
    Next Article Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs

    Related Stories

    First Light Diagnostics Receives FDA Clearance for Rapid Anthrax Test

    December 5, 2023

    Chlorine Exposure Biomarkers in a Large Animal Model

    December 5, 2023

    ARPA-H Announces New Tiered Proposal Submission System to Reduce Applicant Barriers

    December 5, 2023

    Needle-Free Vaccine Patch Against Zika Virus

    December 2, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    Global Biodefense places cookies on your device to enable the best user experience. By using our website, you agree to placement of these cookies. To learn more, read our Privacy Policy.OKPrivacy Policy